Suburban Research Associates is seeking participants ≥ 18 years of age for a generalized anxiety disorder study.
Generalized Anxiety Disorder – Media, PA
Age Range:
18 to 100
Gender:
Male and Female
Location:
Media, Pennsylvania
Compensation* :
up to $100 per appointment
About the Study
This study is approximately 10 weeks (about 2 and a half months) long and includes 9 appointments at our office in Media, PA. The purpose of the study is to evaluate the effectiveness of an investigational medication compared to placebo for the treatment of generalized anxiety disorder when taken with another anti-anxiety medication. This is called adjunctive therapy, or add-on therapy.
There is no cost for participating in our research study. You will be compensated up to $100 per appointment for your time and travel dedicated to completing the clinical trial.
Qualifications
- ≥ 18 years of age
- Are you currently taking at least one of the following medications for your anxiety- paroxetine, venlafaxine XR, duloxetine, escitalopram, buspirone
- Are experiencing symptoms of generalized anxiety disorder
*Please note, other qualifications apply
FEATURED STUDIES
Hypertension & Type 2 Diabetes
Researchers are studying an investigational medication to see how effective it may be in reducing risk of heart failure for
Idiopathic Hypersomnia Study Interest List
Suburban Research Associates is conducting a clinical research study for adults with Idiopathic Hypersomnia for an upcoming study on daytime
Uncontrolled Hypertension
Adults 18–65 with a history of high blood pressure that remains elevated despite treatment may qualify for a study evaluating
Type 2 Diabetes
Adults with type 2 diabetes who have not achieved adequate blood sugar control despite multiple treatments may qualify for a
Weight Management
Adults 18 years and older may qualify for a study evaluating an investigational once-weekly study medication for weight management in
Depression
Are you between 18 and 65 years old and being treated for depression? Even if your symptoms have improved, you